SAKAE ASANUMA
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
RICHARD P. ALDRICH,
JAMES C. BLAIR,
SCOTT C. BRUN,
A. STEWART CAMPBELL,
MICHELE CUCULLU,
ERIC DE LA FORTELLE,
MICHELLE DIPP,
DAVID H. DONABEDIAN,
NORA FREY,
SARKIS K. MAZMANIAN,
SARAH MEIBUSCH,
MARK OHORI,
RONALD C. RENAUD JR.,
REBECCA SENTER,
HENRY C. WOLF,
JEFFREY YOUNG,
JEFFREY E. YOUNG
DIRECTOR
RICHARD P. ALDRICH,
JAMES C. BLAIR,
SCOTT C. BRUN,
A. STEWART CAMPBELL,
MICHELE CUCULLU,
ERIC DE LA FORTELLE,
MICHELLE DIPP,
DAVID H. DONABEDIAN,
NORA FREY,
SARKIS K. MAZMANIAN,
SARAH MEIBUSCH,
MARK OHORI,
RONALD C. RENAUD JR.,
REBECCA SENTER,
HENRY C. WOLF,
JEFFREY YOUNG,
JEFFREY E. YOUNG
DIRECTOR
DARLENE DEPTULA-HICKS,
PAULINA HILL,
RACHEL HUMPHREY,
SARA NAYEEM,
DAVID PARRY,
MARIE-CLAIRE PEAKMAN,
SCOTT PHILLIPS,
DEBANIAN RAY,
TIMOTHY SHANNON,
JAMES TRENKLE,
YUNXIA YANG
DIRECTOR
DANIEL ANDERSON,
THOMAS M. BARNES,
THOMAS EBELING,
ANSBERT GADICKE,
BRIAN GOODMAN,
MORANA JOVAN-EMBIRICOS,
NISHLA KEISER,
ROBERT MARBY,
FRANCESCO MARINCOLA,
JOHN MCCABE,
WILLIAM SHEN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2025-09-17
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2025-01-10
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2023-10-18
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-08-14
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-03-16
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-01-11
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity, Debt
2021-05-11
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2021-05-11
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2020-12-23
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-08-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-08-24
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2019-08-02
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2020-05-07
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2019-08-02
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2019-06-18
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity, Debt
2014-12-02
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2013-10-04